CN107325814B - A kind of fluorescence silicon nano dots and the preparation method and application thereof - Google Patents
A kind of fluorescence silicon nano dots and the preparation method and application thereof Download PDFInfo
- Publication number
- CN107325814B CN107325814B CN201710478865.2A CN201710478865A CN107325814B CN 107325814 B CN107325814 B CN 107325814B CN 201710478865 A CN201710478865 A CN 201710478865A CN 107325814 B CN107325814 B CN 107325814B
- Authority
- CN
- China
- Prior art keywords
- sinds
- fluorescent
- lysosome
- imaging
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 title claims abstract description 27
- 229910052710 silicon Inorganic materials 0.000 title claims abstract description 27
- 239000010703 silicon Substances 0.000 title claims abstract description 27
- 238000002360 preparation method Methods 0.000 title abstract description 11
- 239000002096 quantum dot Substances 0.000 claims abstract description 18
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 claims abstract description 10
- 229910000077 silane Inorganic materials 0.000 claims abstract description 10
- 229930187593 rose bengal Natural products 0.000 claims abstract description 5
- 229940081623 rose bengal Drugs 0.000 claims abstract description 5
- STRXNPAVPKGJQR-UHFFFAOYSA-N rose bengal A Natural products O1C(=O)C(C(=CC=C2Cl)Cl)=C2C21C1=CC(I)=C(O)C(I)=C1OC1=C(I)C(O)=C(I)C=C21 STRXNPAVPKGJQR-UHFFFAOYSA-N 0.000 claims abstract description 5
- IICCLYANAQEHCI-UHFFFAOYSA-N 4,5,6,7-tetrachloro-3',6'-dihydroxy-2',4',5',7'-tetraiodospiro[2-benzofuran-3,9'-xanthene]-1-one Chemical compound O1C(=O)C(C(=C(Cl)C(Cl)=C2Cl)Cl)=C2C21C1=CC(I)=C(O)C(I)=C1OC1=C(I)C(O)=C(I)C=C21 IICCLYANAQEHCI-UHFFFAOYSA-N 0.000 claims abstract 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract 3
- 238000000034 method Methods 0.000 claims description 15
- 239000007850 fluorescent dye Substances 0.000 claims description 13
- 238000006243 chemical reaction Methods 0.000 claims description 10
- 230000002132 lysosomal effect Effects 0.000 claims description 7
- 238000000502 dialysis Methods 0.000 claims description 5
- 239000000243 solution Substances 0.000 claims description 5
- WYTZZXDRDKSJID-UHFFFAOYSA-N (3-aminopropyl)triethoxysilane Chemical compound CCO[Si](OCC)(OCC)CCCN WYTZZXDRDKSJID-UHFFFAOYSA-N 0.000 claims description 3
- SJECZPVISLOESU-UHFFFAOYSA-N 3-trimethoxysilylpropan-1-amine Chemical group CO[Si](OC)(OC)CCCN SJECZPVISLOESU-UHFFFAOYSA-N 0.000 claims description 3
- NHBRUUFBSBSTHM-UHFFFAOYSA-N n'-[2-(3-trimethoxysilylpropylamino)ethyl]ethane-1,2-diamine Chemical compound CO[Si](OC)(OC)CCCNCCNCCN NHBRUUFBSBSTHM-UHFFFAOYSA-N 0.000 claims description 3
- 239000007864 aqueous solution Substances 0.000 claims description 2
- PHQOGHDTIVQXHL-UHFFFAOYSA-N n'-(3-trimethoxysilylpropyl)ethane-1,2-diamine Chemical compound CO[Si](OC)(OC)CCCNCCN PHQOGHDTIVQXHL-UHFFFAOYSA-N 0.000 claims description 2
- 239000002994 raw material Substances 0.000 claims description 2
- 230000035484 reaction time Effects 0.000 claims description 2
- BPSIOYPQMFLKFR-UHFFFAOYSA-N trimethoxy-[3-(oxiran-2-ylmethoxy)propyl]silane Chemical compound CO[Si](OC)(OC)CCCOCC1CO1 BPSIOYPQMFLKFR-UHFFFAOYSA-N 0.000 claims 1
- 210000003712 lysosome Anatomy 0.000 abstract description 63
- 230000001868 lysosomic effect Effects 0.000 abstract description 62
- 210000004027 cell Anatomy 0.000 abstract description 50
- 238000003384 imaging method Methods 0.000 abstract description 46
- 230000000694 effects Effects 0.000 abstract description 22
- 230000007774 longterm Effects 0.000 abstract description 9
- 230000008823 permeabilization Effects 0.000 abstract description 8
- 239000000523 sample Substances 0.000 abstract description 8
- 230000008901 benefit Effects 0.000 abstract description 5
- 238000006862 quantum yield reaction Methods 0.000 abstract description 5
- 238000001027 hydrothermal synthesis Methods 0.000 abstract description 3
- 238000005406 washing Methods 0.000 abstract description 3
- 206010034972 Photosensitivity reaction Diseases 0.000 abstract description 2
- 208000007578 phototoxic dermatitis Diseases 0.000 abstract description 2
- 231100000018 phototoxicity Toxicity 0.000 abstract description 2
- 238000001308 synthesis method Methods 0.000 abstract description 2
- 230000001413 cellular effect Effects 0.000 abstract 1
- 210000004962 mammalian cell Anatomy 0.000 abstract 1
- 230000005284 excitation Effects 0.000 description 10
- 238000010586 diagram Methods 0.000 description 9
- 239000000975 dye Substances 0.000 description 9
- 238000004113 cell culture Methods 0.000 description 8
- 239000001963 growth medium Substances 0.000 description 8
- 238000010186 staining Methods 0.000 description 8
- HXMVNCMPQGPRLN-UHFFFAOYSA-N 2-hydroxyputrescine Chemical compound NCCC(O)CN HXMVNCMPQGPRLN-UHFFFAOYSA-N 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 230000002378 acidificating effect Effects 0.000 description 5
- 238000004140 cleaning Methods 0.000 description 5
- 231100000135 cytotoxicity Toxicity 0.000 description 5
- 230000003013 cytotoxicity Effects 0.000 description 5
- 239000002086 nanomaterial Substances 0.000 description 5
- 239000002105 nanoparticle Substances 0.000 description 5
- 229910002091 carbon monoxide Inorganic materials 0.000 description 4
- 230000008045 co-localization Effects 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- AZJPTIGZZTZIDR-UHFFFAOYSA-L rose bengal Chemical compound [K+].[K+].[O-]C(=O)C1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1C1=C2C=C(I)C(=O)C(I)=C2OC2=C(I)C([O-])=C(I)C=C21 AZJPTIGZZTZIDR-UHFFFAOYSA-L 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- PRDFBSVERLRRMY-UHFFFAOYSA-N 2'-(4-ethoxyphenyl)-5-(4-methylpiperazin-1-yl)-2,5'-bibenzimidazole Chemical compound C1=CC(OCC)=CC=C1C1=NC2=CC=C(C=3NC4=CC(=CC=C4N=3)N3CCN(C)CC3)C=C2N1 PRDFBSVERLRRMY-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 240000008254 Rosa chinensis Species 0.000 description 2
- 235000000664 Rosa chinensis Nutrition 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000008033 biological extinction Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000000799 fluorescence microscopy Methods 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 210000004940 nucleus Anatomy 0.000 description 2
- 210000003463 organelle Anatomy 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 239000004065 semiconductor Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 229910021642 ultra pure water Inorganic materials 0.000 description 2
- 239000012498 ultrapure water Substances 0.000 description 2
- -1 3-[2-(2-aminoethyl) (amino)ethylamino]propyltrimethoxysilane Chemical compound 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical class [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 238000003917 TEM image Methods 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- DPKHZNPWBDQZCN-UHFFFAOYSA-N acridine orange free base Chemical compound C1=CC(N(C)C)=CC2=NC3=CC(N(C)C)=CC=C3C=C21 DPKHZNPWBDQZCN-UHFFFAOYSA-N 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 230000004900 autophagic degradation Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- DZBUGLKDJFMEHC-UHFFFAOYSA-N benzoquinolinylidene Natural products C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- UHYPYGJEEGLRJD-UHFFFAOYSA-N cadmium(2+);selenium(2-) Chemical compound [Se-2].[Cd+2] UHYPYGJEEGLRJD-UHFFFAOYSA-N 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 210000003855 cell nucleus Anatomy 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 210000004292 cytoskeleton Anatomy 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002284 excitation--emission spectrum Methods 0.000 description 1
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 230000031146 intracellular signal transduction Effects 0.000 description 1
- 229940056932 lead sulfide Drugs 0.000 description 1
- 229910052981 lead sulfide Inorganic materials 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 210000005265 lung cell Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- PGSADBUBUOPOJS-UHFFFAOYSA-N neutral red Chemical compound Cl.C1=C(C)C(N)=CC2=NC3=CC(N(C)C)=CC=C3N=C21 PGSADBUBUOPOJS-UHFFFAOYSA-N 0.000 description 1
- 229910000510 noble metal Inorganic materials 0.000 description 1
- 210000000633 nuclear envelope Anatomy 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000001044 red dye Substances 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000012128 staining reagent Substances 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 230000007838 tissue remodeling Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000002371 ultraviolet--visible spectrum Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/08—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials
- C09K11/59—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials containing silicon
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y20/00—Nanooptics, e.g. quantum optics or photonic crystals
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y40/00—Manufacture or treatment of nanostructures
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/645—Specially adapted constructive features of fluorimeters
- G01N21/6456—Spatial resolved fluorescence measurements; Imaging
- G01N21/6458—Fluorescence microscopy
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nanotechnology (AREA)
- Physics & Mathematics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Crystallography & Structural Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Inorganic Chemistry (AREA)
- Optics & Photonics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- Manufacturing & Machinery (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
Abstract
本发明公开了一种荧光硅纳米点(SiNDs),它是由硅烷和孟加拉玫瑰红以水热法一步制备得到的。与现有技术相比,本发明所制备的SiNDs具有超高的荧光量子产率(100%),且能实现对哺乳动物细胞溶酶体的长时间特异成像。此外,该SiNDs的溶酶体成像效果不受细胞清洗、固定和透化等影响,具有耐清洗、耐固定和耐透化的优点。同时,该SiNDs还具有制备成本低、合成方法简单、水分散性好、荧光发射峰宽窄、光稳定性好、细胞相容性好、细胞光毒性低等优点,有望成为新型的溶酶体荧光探针。The invention discloses a fluorescent silicon nano-dot (SiNDs), which is prepared by one-step hydrothermal method from silane and rose bengal. Compared with the prior art, the SiNDs prepared by the present invention have ultra-high fluorescence quantum yield (100%), and can realize long-term specific imaging of mammalian cell lysosomes. In addition, the lysosome imaging effect of the SiNDs is not affected by cell washing, fixation, and permeabilization, and has the advantages of resistance to washing, fixation, and permeabilization. At the same time, the SiNDs also have the advantages of low preparation cost, simple synthesis method, good water dispersibility, narrow fluorescence emission peak width, good photostability, good cytocompatibility, and low cellular phototoxicity. probe.
Description
技术领域technical field
本发明属于纳米材料和生物技术领域,具体涉及一种荧光硅纳米点及其制备方法与应用。The invention belongs to the field of nano-materials and biotechnology, and in particular relates to a fluorescent silicon nano-dot and its preparation method and application.
背景技术Background technique
荧光材料在生物医学中有广泛的应用。与传统的有机荧光小分子相比,荧光纳米材料因为其具有较好的光稳定、可调的激发发射波长等优点,近些年受到广泛关注。目前已有的荧光纳米材料种类很多,但它们都存在一定的缺点,比如:传统的半导体量子点(如硒化镉、硫化铅等)一般含有毒性较大的重金属元素,所以其在生物医学中的使用剂量受到很大限制;贵金属纳米簇(如金纳米簇、银纳米簇)和上转换纳米颗粒的生物相容性虽然好于半导体量子点,但其量子产率一般较低,成像效果不佳;聚合物量子点的合成方法较为复杂,同时对聚合物量子点表面修饰可能会对其荧光性质有较大影响;碳点和石墨烯量子点的荧光发射峰较宽,同时还具有多色发光的性质,不利于与其他探针同时使用;其他新型纳米点(如黑磷量子点)则存在表面不易修饰、制备条件苛刻等问题。因此,开发性能优异且符合生物医学意义的超亮荧光纳米材料具有重要意义。Fluorescent materials are widely used in biomedicine. Compared with traditional organic fluorescent small molecules, fluorescent nanomaterials have attracted extensive attention in recent years because of their advantages such as better photostability and tunable excitation and emission wavelengths. At present, there are many types of fluorescent nanomaterials, but they all have certain shortcomings. For example, traditional semiconductor quantum dots (such as cadmium selenide, lead sulfide, etc.) generally contain toxic heavy metal elements, so they are widely used in biomedicine. The use dose is greatly limited; although the biocompatibility of noble metal nanoclusters (such as gold nanoclusters, silver nanoclusters) and upconversion nanoparticles is better than that of semiconductor quantum dots, their quantum yields are generally low, and the imaging effect is not good. Good; the synthesis method of polymer quantum dots is relatively complicated, and the surface modification of polymer quantum dots may have a greater impact on its fluorescence properties; the fluorescence emission peaks of carbon dots and graphene quantum dots are broad, and they also have multicolor The nature of luminescence is not conducive to simultaneous use with other probes; other new nanodots (such as black phosphorus quantum dots) have problems such as difficult surface modification and harsh preparation conditions. Therefore, it is of great significance to develop ultra-bright fluorescent nanomaterials with excellent performance and biomedical significance.
另一方面,溶酶体是真核细胞中的关键细胞器,为单层膜包被的囊状结构,内含多种酸性水解酶,可分解和消化细胞内多种外源性和内源性的分子和物质,是细胞的消化中心。溶酶体还在细胞凋亡、细胞自噬、细胞内胆固醇平衡、质膜修复、细胞骨架和组织重建、病原体防御以及细胞内信号转导等一系列生理过程中起重要作用。因此,对溶酶体的数量、大小和形貌等的观察和示踪对于了解细胞的行为和命运非常重要。与其他细胞器相比,溶酶体内呈酸性(pH 4.5–5.0),因此通常使用能够靶向酸性环境的分子来实现溶酶体成像。比如,3-(2,4-二硝基苯胺)-3’-氨基-N-甲基二丙胺(DAMP)是一种常用的溶酶体靶向分子,但由于该分子自身没有荧光,因此需要在该分子的伯胺基团上接枝荧光分子才能实现溶酶体成像。一些荧光分子(如中性红和吖啶橙)虽然可以实现溶酶体的成像,但它们同时也会对细胞核内酸性的核酸成像。目前商品化的溶酶体荧光探针(如Thermo Fisher公司的LysoTracker系列染料)有较好的溶酶体成像效果,但其合成成本较高、光稳定性不佳且溶酶体成像时间短。同时,该类荧光探针表面无修饰基团,无法对其进行进一步修饰和应用。新兴的荧光纳米材料被认为是解决上述问题的有效方法。例如,Lin等制备的有机荧光纳米颗粒(PVP和BPVP)虽可靶向癌细胞的溶酶体,但不能实现正常细胞的溶酶体成像(Org.Biomol.Chem.,2009,7,2036.)。Dekiwadia等在金纳米颗粒表面修饰了荧光分子FITC和可靶向溶酶体的多肽后,实现了对溶酶体的成像(J.Pept.Sci.,2012,18,527.)。但是上述方法都没有评价纳米颗粒对固定和透化后的细胞溶酶体成像效果。此外,长时间实时观测溶酶体行为对研究细胞的生理变化有着重要作用,而上述方法都不能实现活细胞溶酶体的长时间成像。因此,亟需发展一种性能良好的荧光纳米颗粒作为长时间观测溶酶体的荧光探针,以实现对活细胞溶酶体的长时间成像和对固定和透化后细胞的溶酶体成像。On the other hand, lysosome is a key organelle in eukaryotic cells. It is a sac-like structure covered by a single membrane and contains a variety of acid hydrolases, which can decompose and digest a variety of exogenous and endogenous substances in the cell. Molecules and substances that are the digestive center of the cell. Lysosomes also play an important role in a series of physiological processes such as apoptosis, autophagy, intracellular cholesterol balance, plasma membrane repair, cytoskeleton and tissue remodeling, pathogen defense, and intracellular signal transduction. Therefore, the observation and tracking of the number, size and shape of lysosomes are very important for understanding the behavior and fate of cells. Lysosomes are acidic (pH 4.5–5.0) compared to other organelles, so molecules that target the acidic environment are often used to enable imaging of lysosomes. For example, 3-(2,4-dinitroaniline)-3'-amino-N-methyldipropylamine (DAMP) is a commonly used lysosome-targeting molecule, but since the molecule itself is not fluorescent, it It is necessary to graft fluorescent molecules on the primary amino groups of the molecule in order to realize lysosome imaging. Some fluorescent molecules (such as neutral red and acridine orange) can image lysosomes, but they can also image acidic nucleic acids in the nucleus. Currently commercialized fluorescent probes for lysosomes (such as LysoTracker series dyes from Thermo Fisher) have good lysosome imaging effects, but their synthesis costs are high, photostability is not good, and lysosome imaging time is short. At the same time, there is no modification group on the surface of this type of fluorescent probe, so it cannot be further modified and applied. Emerging fluorescent nanomaterials are considered to be an effective way to solve the above problems. For example, although the organic fluorescent nanoparticles (PVP and BPVP) prepared by Lin et al. can target the lysosomes of cancer cells, they cannot realize the lysosome imaging of normal cells (Org. Biomol. Chem., 2009, 7, 2036. ). Dekiwadia et al. modified the fluorescent molecule FITC and lysosome-targeting polypeptides on the surface of gold nanoparticles, and realized imaging of lysosomes (J. Pept. Sci., 2012, 18, 527.). However, none of the above methods evaluated the imaging effect of nanoparticles on fixed and permeabilized cell lysosomes. In addition, long-term real-time observation of lysosome behavior plays an important role in the study of physiological changes in cells, but none of the above methods can achieve long-term imaging of lysosomes in living cells. Therefore, it is urgent to develop a fluorescent nanoparticle with good performance as a fluorescent probe for long-term observation of lysosomes, so as to realize long-term imaging of lysosomes in living cells and imaging of lysosomes in fixed and permeabilized cells. .
发明内容Contents of the invention
本发明要解决的技术问题是提供一种荧光硅纳米点(SiNDs),以实现超长时间、耐清洗、耐固定、耐透化的溶酶体成像,解决了现有技术存在的成本高,稳定性差和成像时间短等问题。The technical problem to be solved in the present invention is to provide a fluorescent silicon nano-dot (SiNDs) to realize ultra-long-time, cleaning-resistant, fix-resistant, and permeabilization-resistant lysosome imaging, which solves the high cost of the existing technology, Problems such as poor stability and short imaging time.
本发明还要解决的技术问题是提供该荧光硅纳米点的制备方法和应用。The technical problem to be solved by the invention is to provide the preparation method and application of the fluorescent silicon nano-dot.
为解决上述技术问题,本发明采用的技术方案如下:In order to solve the problems of the technologies described above, the technical scheme adopted in the present invention is as follows:
一种荧光硅纳米点,它包括如下质量份数的组分:A fluorescent silicon nano-dot, which includes the following components in parts by mass:
水溶性硅烷 100份;100 parts of water-soluble silane;
孟加拉玫瑰红 1~10份。Bengal rose red 1 to 10 parts.
其中,优选如下质量份数的组分:Wherein, the component of preferred following mass parts:
水溶性硅烷 100份;100 parts of water-soluble silane;
孟加拉玫瑰红 3份。Rose Bengal 3 parts.
其中,所述的水溶性硅烷为氨丙基三甲氧基硅烷(APTMS)、氨丙基三乙氧基硅烷(APTES)、3-(2-氨基乙基氨基)丙基三甲氧基硅烷(DAMO)、3-[2-(2-氨基乙基氨基)乙基氨基]丙基三甲氧基硅烷(AEEA)或γ-缩水甘油醚氧丙基三甲氧基硅烷(GPTMS),优选3-[2-(2-氨基乙基氨基)乙基氨基]丙基三甲氧基硅烷(AEEA)。Wherein, the water-soluble silane is aminopropyltrimethoxysilane (APTMS), aminopropyltriethoxysilane (APTES), 3-(2-aminoethylamino)propyltrimethoxysilane (DAMO ), 3-[2-(2-aminoethylamino)ethylamino]propyltrimethoxysilane (AEEA) or γ-glycidyl etheroxypropyltrimethoxysilane (GPTMS), preferably 3-[2 - (2-Aminoethylamino)ethylamino]propyltrimethoxysilane (AEEA).
上述荧光硅纳米点的制备方法,它包括如下步骤:The preparation method of above-mentioned fluorescent silicon nano-dot, it comprises the steps:
取配方量的孟加拉玫瑰红溶于超纯水中,加入配方量的水溶性硅烷后进行反应;反应完成后,降至室温的反应液经透析得到荧光硅纳米点水溶液。The formula amount of rose bengal is dissolved in ultrapure water, and the formula amount of water-soluble silane is added to react; after the reaction is completed, the reaction solution cooled to room temperature is dialyzed to obtain an aqueous solution of fluorescent silicon nano-dots.
其中,in,
反应温度为120~250℃,优选160℃;The reaction temperature is 120-250°C, preferably 160°C;
反应时间为2~24h,优选3h;The reaction time is 2 to 24 hours, preferably 3 hours;
反应装置优选为水热反应釜。The reaction device is preferably a hydrothermal reaction kettle.
其中,透析所用透析袋的截留分子量为500-1000。Wherein, the molecular weight cut-off of the dialysis bag used for dialysis is 500-1000.
上述荧光硅纳米点在作为溶酶体荧光探针中的应用也在本发明的保护范围之内。The application of the above-mentioned fluorescent silicon nano-dots as lysosome fluorescent probes is also within the protection scope of the present invention.
孟加拉玫瑰红在制备荧光硅纳米点中的应用也在本发明的保护范围之内;其中,所述的制备荧光硅纳米点是指与水溶性硅烷(优选3-[2-(2-氨基乙基氨基)乙基氨基]丙基三甲氧基硅烷)参照前述的方法进行制备。The application of Rose Bengal in the preparation of fluorescent silicon nano-dots is also within the protection scope of the present invention; wherein, the preparation of fluorescent silicon nano-dots refers to the use of water-soluble silane (preferably 3-[2-(2-aminoethyl) (amino)ethylamino]propyltrimethoxysilane) was prepared with reference to the aforementioned method.
本发明中,孟加拉玫瑰红不仅仅是作为染色剂来使用,而是参与了荧光硅点的合成,其对荧光硅点的合成具有重要作用,不可将其替换为其他染色剂。In the present invention, Rose Bengal is not only used as a dye, but participates in the synthesis of fluorescent silicon dots, which plays an important role in the synthesis of fluorescent silicon dots, and cannot be replaced by other dyes.
有益效果:Beneficial effect:
与现有技术相比,本发明具有如下优势:Compared with the prior art, the present invention has the following advantages:
(1)超高的荧光量子产率:该荧光硅纳米点量子产率可高达100%,仅20μg/mL的样品浓度就可获得优异的溶酶体成像效果;(1) Ultra-high fluorescence quantum yield: the quantum yield of the fluorescent silicon nanodots can be as high as 100%, and only a sample concentration of 20 μg/mL can obtain excellent lysosome imaging effect;
(2)极佳的溶酶体特异靶向性:与商品化的溶酶体探针共定位率高达98%以上,并且该探针即使长时间与细胞孵育,仍然只存在于溶酶体中;(2) Excellent lysosome-specific targeting: the co-localization rate with commercially available lysosome probes is as high as 98%, and the probe still only exists in lysosomes even if it is incubated with cells for a long time ;
(3)能实现超长时间的溶酶体成像:该探针与细胞孵育并经磷酸缓冲液洗涤后,在48h内仍然有较好的溶酶体成像效果,而商品化的溶酶体探针仅在2h内有较好的溶酶体成像效果;(3) Ultra-long time imaging of lysosomes can be realized: after the probe is incubated with cells and washed with phosphate buffer, it still has a good imaging effect of lysosomes within 48 hours, while the commercial lysosome probes The needle has a better lysosome imaging effect within 2 hours;
(4)具有优异的抗光漂白能力:该硅纳米点在激光照射下不易被光漂白,其光稳定性好于商品化溶酶体染料,因此可以实现长时间连续成像观察;(4) Excellent anti-photobleaching ability: the silicon nanodot is not easy to be photobleached under laser irradiation, and its photostability is better than commercial lysosomal dyes, so it can realize long-term continuous imaging observation;
(5)具有良好的耐清洗、耐固定、耐透化能力:在细胞多次清洗、固定、透化后,该硅纳米点仍能对溶酶体有较好的成像效果;(5) Good resistance to cleaning, fixation, and permeabilization: After repeated cleaning, fixation, and permeabilization of cells, the silicon nanodots can still have a good imaging effect on lysosomes;
(6)具有较好的生物相容性:经细胞毒性评价实验,该硅纳米点在500μg/mL及以下的浓度时,对细胞的毒性很低;并且用激光长时间照射后,其细胞毒性仍然很低,证明该材料具有很好的生物相容性和较低的光毒性;(6) It has good biocompatibility: through the cytotoxicity evaluation experiment, when the concentration of the silicon nano-dot is 500 μg/mL and below, the toxicity to cells is very low; and after long-term irradiation with laser, its cytotoxicity Still very low, proving that the material has good biocompatibility and low phototoxicity;
(7)本发明制备方法简单、原料价廉易得、可实现大量制备。(7) The preparation method of the present invention is simple, the raw materials are cheap and easy to obtain, and large-scale preparation can be realized.
附图说明Description of drawings
图1为实施例1中用硅烷试剂AEEA和孟加拉玫瑰红制备超亮荧光硅纳米点(SiNDs)的示意图;Fig. 1 is the schematic diagram that prepares ultra-bright fluorescent silicon nano-dots (SiNDs) with silane reagent AEEA and Bengal Rose Bengal in embodiment 1;
图2为实施例1中制得的SiNDs的透射电子显微镜图;Fig. 2 is the transmission electron micrograph of the SiNDs that makes in embodiment 1;
图3为实施例1中制得的SiNDs的粒径统计结果图;Fig. 3 is the particle size statistical result figure of the SiNDs that makes in embodiment 1;
图4为实施例1中制得的SiNDs的紫外–可见吸收光谱图;Fig. 4 is the ultraviolet-visible absorption spectrogram of the SiNDs that makes in embodiment 1;
图5为实施例1中制得的SiNDs的荧光激发和发射光谱图;Fig. 5 is the fluorescence excitation and emission spectrogram of the SiNDs that make in embodiment 1;
图6为实施例1中制得的SiNDs在不同pH环境中650nm处的消光度图;Fig. 6 is the extinction figure at 650nm of SiNDs prepared in embodiment 1 in different pH environments;
图7为实施例1中制得的SiNDs在A549细胞中孵育不同时间后的溶酶体成像效果图;Fig. 7 is the effect diagram of lysosome imaging after the SiNDs prepared in Example 1 were incubated in A549 cells for different time;
图8为商品化的绿色溶酶体荧光染料LysoTracker Green(LT-Green)与A549细胞孵育不同时间后的溶酶体成像效果图;Fig. 8 is the effect diagram of lysosome imaging after incubation of commercial green lysosome fluorescent dye LysoTracker Green (LT-Green) with A549 cells for different time;
图9为商品化的红色溶酶体荧光染料LysoTracker Red(LT-Red)与A549细胞孵育不同时间后的溶酶体成像效果图;Figure 9 is the lysosome imaging effect diagram after the commercial red lysosome fluorescent dye LysoTracker Red (LT-Red) was incubated with A549 cells for different time;
图10为实施例1中制得的SiNDs与LT-Green和LT-Red在清洗后放置不同时间段的溶酶体成像效果比较图;Fig. 10 is a comparison diagram of lysosome imaging effects of SiNDs prepared in Example 1 and LT-Green and LT-Red after cleaning for different periods of time;
图11为实施例1中制得的SiNDs与LT-Red在激光下照射不同时间后的荧光稳定性比较图;Fig. 11 is a comparison diagram of the fluorescence stability of SiNDs prepared in Example 1 and LT-Red after irradiation with laser light for different times;
图12为实施例1中制得的SiNDs与LT-Green和LT-Red在A549细胞中耐固定和耐透化效果比较图;Fig. 12 is a comparison diagram of SiNDs prepared in Example 1 and LT-Green and LT-Red in A549 cells in resistance to fixation and resistance to permeabilization;
图13为实施例1中制得的SiNDs在不同细胞系中的溶酶体成像效果图;Fig. 13 is a lysosome imaging effect diagram of SiNDs prepared in Example 1 in different cell lines;
图14为实施例1中制得的SiNDs在A549细胞中于光照和正常条件下的细胞毒性图。Fig. 14 is the cytotoxicity graph of SiNDs prepared in Example 1 in A549 cells under light and normal conditions.
具体实施方式Detailed ways
实施例1Example 1
以AEEA为例,制备荧光硅纳米点,包括以下步骤:Taking AEEA as an example, the preparation of fluorescent silicon nanodots includes the following steps:
(1)称取孟加拉玫瑰红并使其充分溶解于超纯水中,加入适当体积的AEEA,使AEEA和孟加拉玫瑰红的质量比为100:3。将二者充分混匀并转移至水热反应釜中;(1) Weigh Rose Bengal and fully dissolve it in ultrapure water, add an appropriate volume of AEEA so that the mass ratio of AEEA to Rose Bengal is 100:3. The two are fully mixed and transferred to a hydrothermal reaction kettle;
(2)反应:在水热反应釜中以160℃反应3h,形成硅纳米点溶液;(2) Reaction: React at 160°C for 3 hours in a hydrothermal reactor to form a silicon nanodot solution;
(3)纯化:透析即得目标超亮荧光硅纳米点溶液。(3) Purification: the target ultra-bright fluorescent silicon nano-dot solution is obtained by dialysis.
该反应的示意图见图1,制备得到的SiNDs的透射电子显微镜结果见图2,其粒径分布统计结果见图3,,其紫外–可见吸收光谱见图4,其荧光激发发射光谱见图5,其在不同pH环境中650nm处的消光度见图6。由以上各图可知,制得的SiNDs呈均匀球状,粒径大致为2.5nm,其最大紫外吸收峰位于511nm处,最大激发波长和最大发射波长分别为511nm和525nm。经计算,该SiNDs的荧光量子产率可高达100%。特别地,由图6可知该SiNDs在弱酸性环境条件下易聚集沉淀,这一特性使其在进入细胞内酸性溶酶体中导致颗粒聚集,从而实现长时间的溶酶体成像。The schematic diagram of the reaction is shown in Figure 1, the transmission electron microscope results of the prepared SiNDs are shown in Figure 2, the statistical results of the particle size distribution are shown in Figure 3, the UV-Vis absorption spectrum is shown in Figure 4, and the fluorescence excitation emission spectrum is shown in Figure 5 , its extinction at 650nm in different pH environments is shown in Figure 6. It can be seen from the above figures that the prepared SiNDs are uniform spherical, with a particle size of approximately 2.5nm, its maximum ultraviolet absorption peak is located at 511nm, and its maximum excitation wavelength and maximum emission wavelength are 511nm and 525nm, respectively. It is calculated that the fluorescence quantum yield of the SiNDs can be as high as 100%. In particular, it can be seen from Figure 6 that the SiNDs are easy to aggregate and precipitate under weakly acidic environmental conditions. This characteristic makes it cause particle aggregation when entering the acidic lysosome in the cell, thereby realizing long-term lysosome imaging.
实施例2Example 2
测试实施例1所制得的SiNDs对A549细胞的溶酶体成像效果,方法如下:The lysosome imaging effect of SiNDs prepared in Example 1 on A549 cells was tested as follows:
(1)细胞培养:将A549细胞以5×103个/孔的密度将种于96孔板中,于37℃、5%CO2环境中培养24h;(1) Cell culture: A549 cells were seeded in a 96-well plate at a density of 5×10 3 cells/well, and cultured at 37°C and 5% CO 2 for 24 hours;
(2)细胞染色:将每个孔中的培养液换成含20 g/mL SiNDs的新鲜培养液,于37℃、5%CO2环境中分别培养2、4、18和24h后,用磷酸缓冲液(PBS)清洗2遍。而后,用商品化的红色溶酶体荧光染料(LT-Red)和细胞核染色试剂(Hoechst 33342)分别染色30和10分钟。最后,用PBS清洗细胞2遍;(2) Cell staining: the culture medium in each well was replaced with fresh culture medium containing 20 g/mL SiNDs, cultured at 37°C and 5% CO2 for 2 , 4, 18 and 24 h, and then treated with phosphoric acid Buffer (PBS) washed 2 times. Then, stain with commercial red lysosomal fluorescent dye (LT-Red) and cell nucleus staining reagent (Hoechst 33342) for 30 and 10 minutes, respectively. Finally, wash the cells twice with PBS;
(3)共聚焦荧光显微镜成像观测:用波长为405、488和552nm激光作为激发光,Hoechst 33342染料在405nm激发光激发下发射蓝色荧光,而SiNDs在488nm激发光激发下发出绿色荧光,LT-Red染料在552nm激光下则呈红色荧光。(3) Confocal fluorescence microscope imaging observation: using lasers with wavelengths of 405, 488 and 552nm as excitation light, Hoechst 33342 dye emits blue fluorescence under excitation of 405nm excitation light, while SiNDs emits green fluorescence under excitation of 488nm excitation light, LT -Red dye exhibits red fluorescence under 552nm laser light.
溶酶体成像和共定位结果见图7。由图可见,该SiNDs进入细胞后主要分布于一些点状位置,通过与红色的商品化溶酶体荧光染料(LT-Red)共定位分析后,证实该SiNDs点亮的区域为溶酶体,且与溶酶体染料共定位率经计算后高达98%。此外,即使将加药时间延长至24h,该SiNDs仍停留于溶酶体中。因此,本发明合成的SiNDs靶向溶酶体的能力不会随加药时间的改变而不同,体现了其溶酶体成像的稳定性。The results of lysosome imaging and co-localization are shown in Figure 7. It can be seen from the figure that the SiNDs are mainly distributed in some punctate positions after entering the cells. After co-localization analysis with a commercially available red lysosomal fluorescent dye (LT-Red), it is confirmed that the lit area of the SiNDs is the lysosome. And the calculated co-localization rate with lysosome dyes is as high as 98%. In addition, the SiNDs remained in lysosomes even when the dosing time was extended to 24 h. Therefore, the ability of SiNDs synthesized in the present invention to target lysosomes will not vary with the time of drug addition, reflecting the stability of its lysosome imaging.
实施例3和4Examples 3 and 4
测试商品化的溶酶体绿色荧光染料(LT-Green)和红色荧光染料(LT-Red)对A549细胞的溶酶体成像效果。The lysosome imaging effect of commercial lysosomal green fluorescent dye (LT-Green) and red fluorescent dye (LT-Red) on A549 cells was tested.
实施例3和4的操作过程与实施例1基本相同,只需将步骤(2)中SiNDs换成1LT-Green和LT-Red分别培养30min,4h和8h。The operation process of Examples 3 and 4 is basically the same as that of Example 1, only need to replace SiNDs in step (2) with 1 LT-Green and LT-Red for 30 min, 4 h and 8 h respectively.
溶酶体成像效果见图8和9。观察图8和图9可知,加药时间的改变对绿色的溶酶体荧光染料LT-Green的影响甚微,但却极大程度的改变了LT-Red的染色位点。随加药时间延长至4h,LT-Red转移至除溶酶体之外的细胞质和细胞核膜等区域,甚至在8h的时候,有些染料已进入细胞核。由此可见,较LT-Red而言,本发明合成的SiNDs更适用于长时间跟踪溶酶体成像。The effects of lysosome imaging are shown in Figures 8 and 9. Observing Figures 8 and 9, it can be seen that the change of dosing time has little effect on the green lysosomal fluorescent dye LT-Green, but greatly changes the staining site of LT-Red. As the dosing time was extended to 4h, LT-Red was transferred to the cytoplasm and nuclear membrane other than the lysosome, and even at 8h, some dyes had entered the nucleus. It can be seen that, compared with LT-Red, the SiNDs synthesized in the present invention are more suitable for long-term tracking of lysosome imaging.
实施例5Example 5
测试实施例1制得的SiNDs与商品化的LT-Green和LT-Red在清洗后的溶酶体成像稳定性,方法如下:The lysosome imaging stability of the SiNDs prepared in Example 1 and commercial LT-Green and LT-Red after cleaning was tested as follows:
(1)细胞培养:该过程与实施例2中的步骤(1)一致;(1) Cell culture: the process is consistent with step (1) in Example 2;
(2)细胞染色与清洗:将细胞培养孔中的培养液分别换成含SiNDs(20μg/mL),LT-Green(1μM)和LT-Red(1μM)的新鲜培养液,对应孔染色2h、30min和30min。经PBS清洗两遍后,于37℃、5%CO2的黑暗环境中分别培养0、1、2、4、12、24、36和48h后,置于共聚焦荧光显微镜下观察;(2) Cell staining and washing: replace the culture medium in the cell culture wells with fresh culture medium containing SiNDs (20 μg/mL), LT-Green (1 μM) and LT-Red (1 μM), and stain the corresponding wells for 2 h, 30min and 30min. After being washed twice with PBS, cultured in a dark environment of 37°C and 5% CO 2 for 0, 1, 2, 4, 12, 24, 36 and 48 hours, observed under a confocal fluorescence microscope;
(3)溶酶体成像效果观测:用488nm和552nm激光作为激发光。其中,SiNDs和LT-Green在488nm激光下发出绿色荧光,LT-Red在552nm激光下发射红色荧光。(3) Observation of lysosome imaging effects: 488nm and 552nm lasers were used as excitation light. Among them, SiNDs and LT-Green emit green fluorescence under 488nm laser, and LT-Red emit red fluorescence under 552nm laser.
荧光成像结果见图10。对比三种染料的成像结果可知,商品化的溶酶体染料LT-Green和LT-Red在细胞经清洗后的2h内,二者的荧光均显著减弱。明显不同的是,本发明制备的SiNDs在细胞经清洗后48h内仍具有很强的荧光,因此可实现超长时间的溶酶体清晰成像。The results of fluorescence imaging are shown in Figure 10. Comparing the imaging results of the three dyes, it can be seen that the fluorescence of the commercially available lysosomal dyes LT-Green and LT-Red decreased significantly within 2 hours after the cells were washed. The obvious difference is that the SiNDs prepared by the present invention still have strong fluorescence within 48 hours after the cells are washed, so clear imaging of lysosomes can be achieved for a long time.
实施例6Example 6
测试实施例1制得的SiNDs与商品化的LT-Red在激光下照射不同时间后的溶酶体荧光成像稳定性。方法如下:The stability of lysosome fluorescence imaging of the SiNDs prepared in Example 1 and the commercialized LT-Red after irradiation with laser light for different periods of time was tested. Methods as below:
(1)细胞培养:该过程与实施例2中的步骤(1)一致;(1) Cell culture: the process is consistent with step (1) in Example 2;
(2)细胞染色:将细胞培养孔中的培养液分别换成含SiNDs(20μg/mL)和LT-Red(1μM)的新鲜培养液,分别染色2h和30min后,用PBS清洗细胞两遍;(2) Cell staining: replace the culture medium in the cell culture wells with fresh culture medium containing SiNDs (20 μg/mL) and LT-Red (1 μM), respectively, and wash the cells twice with PBS after staining for 2 h and 30 min, respectively;
(3)激光照射:将染色后的细胞置于488nm激光下分别照射0、0.5、1、3、5、10、15、20和30min后,用共聚焦荧光显微镜观察;(3) Laser irradiation: After the stained cells were irradiated with a 488nm laser for 0, 0.5, 1, 3, 5, 10, 15, 20 and 30 min respectively, they were observed with a confocal fluorescence microscope;
(4)荧光稳定性观测:用488nm和552nm激光作为激发光。其中,SiNDs在488nm激光下发出绿色荧光,LT-Red在552nm激光下发射红色荧光。(4) Observation of fluorescence stability: 488nm and 552nm lasers were used as excitation light. Among them, SiNDs emit green fluorescence under 488nm laser, and LT-Red emit red fluorescence under 552nm laser.
由图11可见,在激光照射3min之内LT-Red的荧光明显减弱,而本发明制得的SiNDs则在照射20min后仍保持清晰的溶酶体成像效果。该实验证实了SiNDs在抗光漂白稳定成像方面的显著优势。It can be seen from Fig. 11 that the fluorescence of LT-Red is significantly weakened within 3 minutes of laser irradiation, while the SiNDs prepared by the present invention still maintain a clear lysosome imaging effect after 20 minutes of irradiation. This experiment confirmed the remarkable advantages of SiNDs in stable imaging against photobleaching.
实施例7Example 7
测试实施例1制得的SiNDs与商品化的LT-Green和LT-Red耐固定和耐透化的能力。步骤如下:The ability of SiNDs prepared in Example 1 and commercially available LT-Green and LT-Red to resist fixation and permeabilization were tested. Proceed as follows:
(1)细胞培养:该过程与实施例2中的步骤(1)一致;(1) Cell culture: the process is consistent with step (1) in Example 2;
(2)细胞染色:该过程与实施例5中的步骤(2)一致,用含SiNDs(20μg/mL),LT-Green(1μM)和LT-Red(1μM)的新鲜培养液分别染色2h,30min和30min。染色后的细胞均置于共聚焦荧光显微镜下观察;(2) Cell staining: This process is consistent with step (2) in Example 5, staining with fresh culture solution containing SiNDs (20 μg/mL), LT-Green (1 μM) and LT-Red (1 μM) for 2 h respectively, 30min and 30min. The stained cells were observed under a confocal fluorescence microscope;
(3)细胞固定:将染色后的细胞置于含4%戊二醛的磷酸缓冲液中30分钟后,用PBS清洗2遍,于共聚焦荧光显微镜下观察溶酶体成像结果;(3) Cell fixation: place the stained cells in phosphate buffer containing 4% glutaraldehyde for 30 minutes, wash them twice with PBS, and observe the lysosome imaging results under a confocal fluorescence microscope;
(4)细胞透化:细胞经固定步骤后,再用含0.1%Triton X-100的磷酸缓冲液处理10分钟,最后用PBS清洗细胞2遍,置于共聚焦荧光显微镜下观察。共聚焦荧光显微镜的设置条件与实施例5中的步骤(3)一致。(4) Cell permeabilization: After the cells were fixed, they were treated with phosphate buffer containing 0.1% Triton X-100 for 10 minutes, and finally the cells were washed twice with PBS, and observed under a confocal fluorescence microscope. The setting conditions of the confocal fluorescence microscope are consistent with step (3) in Example 5.
由图12可知,LT-Green和LT-Red均不适用于经固定和透化后的细胞的溶酶体成像,而本发明制得的溶酶体成像探针具有耐固定和抗透化能力。It can be seen from Figure 12 that neither LT-Green nor LT-Red is suitable for lysosome imaging of fixed and permeabilized cells, while the lysosome imaging probe prepared by the present invention has the ability to resist fixation and anti-permeabilization .
实施例8Example 8
测试实施例1制得的SiNDs在不同细胞系中的溶酶体成像效果,其操作步骤与实施例2大致相同,只需将实施例2中的A549细胞分别换成正常肺细胞AT II、乳腺癌细胞MCF-7和巨噬细胞Raw 264.7,染色时间改为2h即可。To test the lysosome imaging effect of the SiNDs prepared in Example 1 in different cell lines, the operation steps were roughly the same as in Example 2, only the A549 cells in Example 2 were replaced with normal lung cells AT II, mammary gland For cancer cell MCF-7 and macrophage Raw 264.7, the staining time can be changed to 2h.
图13表明本发明合成的SiNDs在不同细胞系中均具有优异的溶酶体成像能力。Figure 13 shows that the SiNDs synthesized by the present invention have excellent lysosome imaging ability in different cell lines.
实施例9Example 9
测试实施例1制得的SiNDs对A549细胞在黑暗条件和光照条件下的细胞毒性,其操作步骤如下:To test the cytotoxicity of the SiNDs prepared in Example 1 to A549 cells under dark and light conditions, the operation steps are as follows:
(1)细胞培养:该过程与实施例2中的步骤(1)一致;(1) Cell culture: the process is consistent with step (1) in Example 2;
(2)SiNDs处理:将细胞培养孔中的培养液分别换成含不同浓度SiNDs的新鲜培养液,SiNDs的浓度梯度为:0,50,100,200,500和1000μg/mL,于37℃、5%CO2环境中培养24h之后。将细胞分为两组,一组置于白光下照射30min,另一组则置于黑暗环境下。随后,将两组细胞均放于37℃、5%CO2环境中培养4h;(2) SiNDs treatment: the culture medium in the cell culture wells was replaced with fresh culture medium containing different concentrations of SiNDs. After culturing for 24 h in a 5% CO 2 environment. The cells were divided into two groups, one group was irradiated with white light for 30 min, and the other group was placed in dark environment. Subsequently, the two groups of cells were cultured at 37°C and 5% CO 2 for 4 hours;
(3)细胞活性检测:通过MTT法检测细胞毒性。(3) Detection of cell activity: the cytotoxicity was detected by MTT method.
细胞存活率结果如图14。由图可知,即使SiNDs的浓度高达200μg/mL,光照和不光照组的细胞均保持90%以上的活性,体现了本发明合成的SiNDs的低毒性,使其成为一种安全的溶酶体成像荧光探针。The results of cell viability are shown in Figure 14. It can be seen from the figure that even if the concentration of SiNDs is as high as 200 μg/mL, the cells in the light and non-light groups maintain more than 90% of the activity, which reflects the low toxicity of the SiNDs synthesized by the present invention, making it a safe lysosome imaging method. fluorescent probe.
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710478865.2A CN107325814B (en) | 2017-06-22 | 2017-06-22 | A kind of fluorescence silicon nano dots and the preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710478865.2A CN107325814B (en) | 2017-06-22 | 2017-06-22 | A kind of fluorescence silicon nano dots and the preparation method and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107325814A CN107325814A (en) | 2017-11-07 |
CN107325814B true CN107325814B (en) | 2018-11-09 |
Family
ID=60195623
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710478865.2A Active CN107325814B (en) | 2017-06-22 | 2017-06-22 | A kind of fluorescence silicon nano dots and the preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107325814B (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108844937B (en) * | 2018-08-07 | 2020-09-08 | 福建中医药大学 | A kind of water-soluble fluorescent silicon dot and its preparation method and application |
CN110031436B (en) * | 2019-04-12 | 2021-04-20 | 济南大学 | A Silicone Fluorescent Probe for Detecting Lipid Droplets |
CN110174387A (en) * | 2019-06-14 | 2019-08-27 | 郑州大学 | A kind of application of fluorescent carbon point in naturally targeting lysosome |
CN110669514B (en) * | 2019-10-23 | 2022-06-24 | 山东师范大学 | Preparation and application of a kind of ultra-bright fluorescent carbon dots |
CN111647400A (en) * | 2020-06-11 | 2020-09-11 | 吉林大学第一医院 | Preparation method of fluorescent organic silicon nano particles |
CN113174255B (en) * | 2021-04-08 | 2022-07-08 | 华南农业大学 | Preparation method and application of water-soluble green fluorescent silanized carbon dots |
CN114214062A (en) * | 2021-12-23 | 2022-03-22 | 郑州中科生物医学工程技术研究院 | Preparation method of fluorine-doped silicon quantum dots and application of fluorine-doped silicon quantum dots in detection of carmine |
CN117801812A (en) * | 2023-12-25 | 2024-04-02 | 中国科学院苏州生物医学工程技术研究所 | Red fluorescent silicon nanodots, preparation method and application thereof |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009096669A (en) * | 2007-10-17 | 2009-05-07 | Konica Minolta Medical & Graphic Inc | Silicon quantum dot and biomaterial labeling agent using the same |
CN103896271B (en) * | 2014-04-11 | 2015-06-17 | 武汉大学 | Method for preparing water-soluble fluorescent silicon quantum dots by using hydrothermal process |
CN104003392B (en) * | 2014-05-05 | 2016-01-06 | 东南大学 | 3-(2-aminoethylamino) propyl trimethoxy silicane is preparing the application in superbright fluorescence silicon quantum dot |
CN104016348B (en) * | 2014-05-05 | 2016-03-16 | 东南大学 | Diethylenetriamine base propyl trimethoxy silicane is preparing the application in water-soluble silicon quantum dot |
CN104306984A (en) * | 2014-11-07 | 2015-01-28 | 东南大学 | Application of water-soluble silicon quantum dots as drug carriers |
CN105586035B (en) * | 2016-03-04 | 2017-11-03 | 南开大学 | A kind of preparation method of the water-soluble silicon quantum dot of highlighted bluish-green fluorescence |
CN105777792B (en) * | 2016-04-21 | 2018-08-21 | 东南大学 | A kind of quaternization fluorescence silicon point and the preparation method and application thereof |
CN106190114A (en) * | 2016-07-13 | 2016-12-07 | 中南民族大学 | A kind of hydro-thermal method or microwave method prepare the method for high yield fluorescence silicon quantum dot |
CN106350061B (en) * | 2016-08-29 | 2019-03-29 | 北京化工大学 | A kind of silicon quantum dot and the preparation method and application thereof |
CN106596482B (en) * | 2016-12-08 | 2019-04-30 | 哈尔滨师范大学 | Fluorescent silicon nanoparticles and their applications in mercury ion detection and fingerprint visualization |
-
2017
- 2017-06-22 CN CN201710478865.2A patent/CN107325814B/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN107325814A (en) | 2017-11-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107325814B (en) | A kind of fluorescence silicon nano dots and the preparation method and application thereof | |
Bai et al. | Carbon dots with absorption red-shifting for two-photon fluorescence imaging of tumor tissue pH and synergistic phototherapy | |
Ali et al. | Fluorescent carbon dots as intracellular imaging probes | |
Hua et al. | Carbon quantum dots with intrinsic mitochondrial targeting ability for mitochondria-based theranostics | |
Xu et al. | Integration of IR‐808 sensitized upconversion nanostructure and MoS2 nanosheet for 808 nm NIR light triggered phototherapy and bioimaging | |
Jiang et al. | Lipid Droplet‐Targetable Fluorescence Guided Photodynamic Therapy of Cancer Cells with an Activatable AIE‐Active Fluorescent Probe for Hydrogen Peroxide | |
Xia et al. | An upconversion nanoparticle–Zinc phthalocyanine based nanophotosensitizer for photodynamic therapy | |
Chu et al. | Fluorescent and photostable silicon nanoparticles sensors for real-time and long-term intracellular pH measurement in live cells | |
Lim et al. | Carbon quantum dots and their applications | |
Jia et al. | Functionalized Eu (III)-based nanoscale metal–organic framework to achieve near-IR-triggered and-targeted two-photon absorption photodynamic therapy | |
Chen et al. | A dual-emission fluorescent nanocomplex of gold-cluster-decorated silica particles for live cell imaging of highly reactive oxygen species | |
Liu et al. | Dye‐Sensitized Rare Earth Nanoparticles with Up/Down Conversion Luminescence for On‐Demand Gas Therapy of Glioblastoma Guided by NIR‐II Fluorescence Imaging | |
Xiang et al. | A multifunctional nanoplatform for lysosome targeted delivery of nitric oxide and photothermal therapy under 808 nm near-infrared light | |
Das et al. | One‐step synthesis of fluorescent carbon dots for bio‐labeling assay | |
Ryplida et al. | Zwitterionic carbon dot-encapsulating pH-responsive mesoporous silica nanoparticles for NIR light-triggered photothermal therapy through pH-controllable release | |
CN110982513B (en) | Preparation method of fluorescent carbon dots and application of fluorescent carbon dots in cell imaging | |
Park et al. | Advanced carbon dots via plasma-induced surface functionalization for fluorescent and bio-medical applications | |
CN104083771A (en) | Fluorescence resonance energy transfer-based tumor imaging and therapeutic targeting system and construction method thereof | |
Thakur et al. | Poly-l-lysine-functionalized green-light-emitting carbon dots as a fluorescence turn-on sensor for ultrasensitive detection of endotoxin | |
Shi et al. | Selective imaging of cancer cells with a pH-activatable lysosome-targeting fluorescent probe | |
Zhao et al. | Bioluminescent microcapsules: applications in activating a photosensitizer | |
CN105368449A (en) | Nitrogen-doped multi-color fluorescent carbon dot and preparation method and application thereof | |
CN111154482B (en) | A kind of biological nanocomposite material and its synthesis method and application | |
Luo et al. | Rose bengal-modified gold nanorods for PTT/PDT antibacterial synergistic therapy | |
Qian et al. | Supramolecular Luminescent Nano‐assemblies Based on Macrocycles and Amphiphiles for Cell Imaging |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |